Stingl Krunoslav, Peters Tobias, Strasser Torsten, Kelbsch Carina, Richter Paul, Wilhelm Helmut, Wilhelm Barbara
Pupil Research Group at the Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
Biomed Tech (Berl). 2018 Nov 27;63(6):729-734. doi: 10.1515/bmt-2017-0029.
Pupillographic campimetry allows measuring the visual field objectively by analyzing the pupil response to perimetric stimuli. One of the drawbacks of this technique, similar to static perimetry, is the need of reliable fixation of the subject. By using stimulus sizes comparable to static perimetry and applying gaze tracking, we enable a retinotopic visual field examination regardless of fixation problems and with an increased stability and improved spatial resolution. Here, we present the results of applying the method in eight normal sighted subjects as well as in three patients suffering from diseases usually diagnosed by perimetry. The results in normal sighted subjects show a reduction in the amplitude of the pupil response with increasing eccentricity as expected. We also demonstrate that gaze-controlled campimetry is able to detect organic visual field defects objectively in a patient group and classify the visual field defects without an organic background. Moreover, we show that our method is able to evaluate the visual field sensitivity loss beyond classical perimetry in patients with late-stage retinitis pigmentosa. Thus, gaze-controlled pupil campimetry can be used in addition to classical perimetry, allowing for an objective monitoring of disease progression, rendering it as a biomarker for novel treatments.
瞳孔视野计通过分析瞳孔对视野刺激的反应来客观测量视野。与静态视野检查类似,该技术的一个缺点是需要受试者可靠地固视。通过使用与静态视野检查相当的刺激大小并应用注视跟踪,我们能够进行视网膜定位视野检查,而无需考虑固视问题,并且具有更高的稳定性和更好的空间分辨率。在此,我们展示了将该方法应用于八名视力正常的受试者以及三名通常通过视野检查诊断疾病的患者的结果。视力正常受试者的结果显示,正如预期的那样,随着离心率增加,瞳孔反应幅度降低。我们还证明,注视控制的视野计能够在患者群体中客观地检测器质性视野缺损,并对没有器质性背景的视野缺损进行分类。此外,我们表明我们的方法能够评估晚期视网膜色素变性患者超出经典视野检查的视野敏感度损失。因此,除了经典视野检查之外,还可以使用注视控制的瞳孔视野计,以便对疾病进展进行客观监测,使其成为新治疗方法的生物标志物。